Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Seer, Inc.

Seer Inc. provides technology for proteomics and genomics research, aiming to eliminate barriers in proteomics advances.

Seer Inc.

Seer | 10,552 followers on LinkedIn. Empowering scientists through unbiased, deep, rapid proteomics at scale | At Seer, we develop innovative solutions that act as a gateway to the proteome. Our goal is to empower the scientific community with tools to achieve exceptional scientiﬁc outcomes. We do this by removing the technological barriers that stand between breakthrough ideas and the information that can make them a reality.

Serafim Batzoglou

Strategic Leader | Builder of Teams | Believer in Continuous Improvement

Erwin Wilbers

VP Data Engineering & Software at Seer | Cloud-Native Proteomics Leader

Theo Platt

Nick Roelofs

Seer

We are thrilled to announce a new co-marketing and sales agreement with Thermo Fisher Scientific to accelerate the adoption of cutting-edge proteomic technologies. This strategic collaboration will integrate Seer’s Proteograph™ Product Suite with Thermo Fisher Scientific’s industry-leading Orbitrap Astral™ mass spectrometers, providing researchers with a powerful, scalable solution for deep, unbiased proteomic analysis at scale. https://lnkd.in/gHY6TiQM #proteomics #collaboration #innovation #lifesciences #ThermoFisher #Seer #scientificbreakthroughs #healthtech #Proteograph

Congratulations to PrognomiQ Inc for their groundbreaking work in leveraging multi-omics data to advance early detection testing for #lungcancer . By reimagining the possibilities in early detection and treatment, PrognomIQ is paving the way to transform patient outcomes and impact millions of lives. Seer is honored to be your partner on this remarkable journey. #improvinghumanhealth #proteomicseducation #proteomicsresearch #proteomicsworkflows #proteomicsdiscovery #proteomicsanalysis #proteomicsapplications #massspectrometry #scientificcollaborations #biomarkerdiscovery #Proteograph #trailblazingscientists #healthcare

Today's the day! Please join us this afternoon at #ASHG24 . This exciting 2-part CoLab will highlight #proteogenomic breakthroughs in #lungcancer and relative energy deficiency in sport (REDs) that leveraged Seer's #ProteographProductSuite . 📊 Unleashing the Power of Multi-omics: A Breakthrough in the Early Detection of Lung Cancer, with Philip Ma , PhD, CEO, President & Founder, PrognomiQ Inc . 🔬 Mouse Model of Relative Energy Deficiency in Sport, with Laura van Rosmalen , PhD, Satchidananda Panda Lab, Salk Institute for Biological Studies . https://lnkd.in/gjG2pvwT #proteogenomicsresearch #genomicsresearch #proteomics #proteomicstechnology #scienceandinnovation #trailblazingscientists #Proteograph

This scientific presentation at American Society of Human Genetics ' #ASHG24 will showcase the exceptional work by Brendan Keating, PhD, et al at NYU Grossman School of Medicine as well as highlight the power of #plasmaproteomics using Seer's #ProteographProductSuite in multi-omics research. We invite you to join us! Date: Wednesday, November 6 Time: 11:15-11:30am (MT) Location: Four Seasons Ballroom 4 Visit the Seer team at Booth 335. https://lnkd.in/gjG2pvwT #proteomicsresearch #genomicsresearch #multiomicsresearch #scienceandinnovation #technology #Proteograph

An exciting 2-part CoLab at #ASHG24 - The Power of Deep Proteomics: Driving the Next Generation of Genomic Research. This session will highlight #proteogenomic breakthroughs in #lungcancer and relative energy deficiency in sport (REDs) that leveraged our #Proteograph Product Suite. Join Seer on November 7 for: 📊 Unleashing the Power of Multi-omics: A Breakthrough in the Early Detection of Lung Cancer, with Philip Ma , PhD, CEO, President & Founder, PrognomiQ Inc . 🔬 Mouse Model of Relative Energy Deficiency in Sport, with Laura van Rosmalen , PhD, Satchidananda Panda Lab, Salk Institute for Biological Studies . DATE: Thursday, November 7. TIME: 2:30-3:00pm (MT). LOCATION: Theatre #1 Exhibit Floor. https://lnkd.in/gjG2pvwT #genomics #proteomics #proteomicsresearch #humanbiology #scienceandinnovation #technology #ProteographProductSuite

We're just a few days away from American Society of Human Genetics ' #ASHG24 in Denver. While attending, we would welcome the opportunity to connect with you, learn about your research, and share how the #Proteograph is enhancing #proteogenomic studies. Please visit us at Booth 335 and meet the team! - Peter Graf , Director of Sales - Ryan Hill, PhD , Director, Field Application Scientist - Spencer Servizi , Regional Business Manager - Shao-Yung (Eric) Chen , Marketing Application Scientist https://lnkd.in/gjG2pvwT #genomics #proteomics #proteomicsresearch #genetics #humanbiology #biomarkerdiscovery #scienceandtechnology

We are looking forward to joining everyone at American Society of Human Genetics ' #ASHG24 in Denver. Scientists are leveraging the #ProteographProductSuite to push the boundaries of their #genomics and #proteomics research and uncover novel biological insights. We welcome the opportunity to explore what proteomics and our technology can do: ⚖️ Deep, unbiased proteomics at scale to complement and enhance advanced genetic research. 🔬 Important insights into protein functions and their genetic foundations. 📊 Integration of proteomics data with genomics data to reveal novel biology. We will be at Booth 335! https://lnkd.in/gjG2pvwT #genomicresearch #proteomicsresearch #proteogenomics #genetics #biomarkerdiscovery #innovation #scienceandtechnology

Thank you to everyone who connected with us at #HUPO2024 and to Human Proteome Organization for such an engaging, highly informative conference. We were so pleased to have the opportunity to join important research discussions with incredible #scientists , industry partners, and customers from around the world, including the many who also enjoyed our photo booth up to the final hour! Let's keep pushing the boundaries of #proteomics together. https://seer.bio/

Have you visited our photo booth at #HUPO2024 yet? There’s still time! Bring your industry friends and colleagues and drop by our Booth 20 and take some pics. The Seer team would love to meet you.

Thank you to everyone who attended Alexey Sukolav's, PhD, presentation today at #HUPO2024 , where he offered further insights into this amazing study done at NYU Langone Transplant Institute. Please visit our team at Booth 20 if you would like to discuss this research in more detail or if you were unable to join us and have questions!

NASDAQ:SEER

Seer Inc.

Last Close

2.24

12/11 19:34

Market Cap

103.25M

Beta: 1.25

Volume Today

199.77K

Avg: 410.54K

PE Ratio

−1.27

PFCF: −1.46

People Not Available